Neoadjuvant therapy (NAT) allows downstaging in some cases of breast cancer. By consequence, it may enable a more conservative surgical approach or make surgery possible in cases ineligible for surgery before NAT. In this article, we review the evidence and management recommendations for optimal surgical treatment in this setting.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Cordoba, O., Carrillo-Guivernau, L., & Reyero-Fernández, C. (2018, August 1). Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy. Breast Care. S. Karger AG. https://doi.org/10.1159/000491760